Chemed (NYSE:CHE) Issues FY 2025 Earnings Guidance

Chemed (NYSE:CHE) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 24.950-25.450 for the period, compared to the consensus EPS estimate of 24.890. The company issued revenue guidance of -.

Analyst Ratings Changes

CHE has been the subject of a number of recent analyst reports. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th. Royal Bank of Canada cut their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th.

Chemed Stock Performance

Shares of NYSE:CHE traded down $3.05 during midday trading on Wednesday, reaching $547.65. 135,136 shares of the company’s stock traded hands, compared to its average volume of 91,578. The company has a market cap of $8.24 billion, a P/E ratio of 27.67, a PEG ratio of 2.15 and a beta of 0.48. The company has a fifty day simple moving average of $543.28 and a two-hundred day simple moving average of $563.22. Chemed has a 1 year low of $512.12 and a 1 year high of $654.62.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be given a $0.50 dividend. The ex-dividend date is Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.37%. Chemed’s dividend payout ratio (DPR) is 10.11%.

Insider Transactions at Chemed

In other news, VP Brian C. Judkins acquired 145 shares of the stock in a transaction that occurred on Monday, December 30th. The shares were bought at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the acquisition, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. This represents a 9.46 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.